WuXi Biologics said its MFG17 biologics drug-substance plant at the Shanghai Fengxian campus completed its first GMP production. MFG17 is the company’s 25th global drug-substance facility and will provide scaled clinical and commercial supply for multiple biologics. The plant is equipped with multiple single-use bioreactors (SUBs), has 9,000‑liter capacity and is designed for about 80–100 drug-substance batches a year.

Financial Times reports Qatari PM Sheikh Mohammed said QatarEnergy is preparing to resume normal operations as the situation in the strait normalizes.

At the opening of MWC Shanghai 2026, MIIT chief engineer Zhong Zhihong said China will maintain a moderately forward stance on new infrastructure and strengthen planning and construction of next‑generation communication and compute networks. He called for advancing dual‑gigabit networks to dual‑10‑gigabit, accelerating a multi‑tier compute‑facility system, and actively deploying low‑altitude information infrastructure and satellite internet to build an integrated space‑air‑ground information network.